Theresa Agovino. 3. prosinca 2006. Pfizer ends cholesterol drug development. Yahoo! News. Associated Press. Inačica izvorne stranice arhivirana 14. prosinca 2006. Pristupljeno 3. prosinca 2006.Each study arm (torcetrapib + Lipitor vs. Lipitor alone) had 7500 patients enrolled; 51 deaths were observed in the Lipitor alone arm, while 82 deaths occurred in the torcetrapib + Lipitor arm.
Theresa Agovino. 3. prosinca 2006. Pfizer ends cholesterol drug development. Yahoo! News. Associated Press. Inačica izvorne stranice arhivirana 14. prosinca 2006. Pristupljeno 3. prosinca 2006.Each study arm (torcetrapib + Lipitor vs. Lipitor alone) had 7500 patients enrolled; 51 deaths were observed in the Lipitor alone arm, while 82 deaths occurred in the torcetrapib + Lipitor arm.